Biotech | May 29, 2022
Zydus receives EIR from USFDA for its injectables manufacturing facility at Jarod
The inspection was a Pre-Approval cum cGMP inspection and it covered 15 ANDAs
The inspection was a Pre-Approval cum cGMP inspection and it covered 15 ANDAs
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
The unit is an oral manufacturing facility at Jedcherla, Hyderabad
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
The drug will be manufactured at the group's formulation facility at SEZ, Ahmedabad
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
This product will be manufactured at Lupin’s Nagpur facility in India
The product will be manufactured at Lupin’s facility in Goa, India
The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC
The product will be manufactured at Lupin’s facility in Goa, India
Subscribe To Our Newsletter & Stay Updated
